Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 5;44(1):367.
doi: 10.1007/s10792-024-03293-5.

Ocular manifestations and treatment progress of Crouzon syndrome

Affiliations
Review

Ocular manifestations and treatment progress of Crouzon syndrome

Shuting Huang et al. Int Ophthalmol. .

Abstract

Purpose: Crouzon syndrome is a congenital genetic disease caused by mutations of the FGFR2 gene on chromosome 10. It is usually inherited in an autosomal dominant pattern and is one of the most common types of craniosynostosis syndromes. This article focuses on the ophthalmology-related aspects of Crouzon syndrome in order to help diagnose and develop personalized treatment plans.

Methods: A combined systematic search of PubMed electronic database by using Boolean operators AND and OR was conducted, choosing the following keywords: "Crouzon", "craniosynostosis", " eye ", " oculus ", " ocular ", " ophthalmic ", " ophthalmologic ", " ophthalmology ", " globe ", " orbit ", " exophthalmos ", " exorbitism ", " keratopathy ", " visual " etc. After the initial screening of these articles, repetitive literatures were excluded.

Results: 47 articles were selected. This article introduces the ocular manifestations, possible pathogenesis and treatment progress in Crouzon syndrome.

Conclusions: The incidence of ocular abnormalities in Crouzon syndrome is very high, such as shallow orbits, exophthalmos, hypertelorism, exposure keratopathy, strabismus, optic neuropathy, ametropia, glaucoma, etc. The pathogenesis of these ocular abnormalities is related to orbital deformities. Most of the treatments are aimed at compensating the abnormal anatomic structure at present.

Keywords: Crouzon syndrome; Ocular manifestations; Pathogenesis; Treatment.

PubMed Disclaimer

Similar articles

References

    1. Olshinka A, Tal D, Gillman L, Ad-El D, Kalish E, Kropach N, Yaacobi DS, Kornreich L, Staffenberg DA (2021) Crouzon syndrome and acanthosis nigricans with fibrous dysplasia of the maxilla: an unreported suggested triad. J Craniofac Surg 32(1):310–312 - PubMed
    1. Lin Y, Gao H, Ai S, Eswarakumar JVP, Zhu Y, Chen C, Li T, Liu B, Jiang H, Liu Y, Li Y, Wu Q, Li H, Liang X, Jin C, Huang X, Lu L (2017) FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome. Mol Med Rep 16(5):5841–5846 - PubMed - PMC
    1. Rostamzad P, Arslan ZF, Mathijssen IMJ, Koudstaal MJ, Pleumeekers MM, Versnel SL, Loudon SE (2022) Prevalence of ocular anomalies in craniosynostosis: a systematic review and meta-analysis. J Clin Med 11(4):1060 - PubMed - PMC
    1. Ke R, Yang X, Tianyi C, Ge M, Lei J, Mu X (2015) The C342R mutation in FGFR2 causes Crouzon syndrome with elbow deformity. J Craniofac Surg 26(2):584–586 - PubMed
    1. Fan J, Li Y, Jia R, Fan X (2018) An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome. BMC Med Genet 19(1):91 - PubMed - PMC

LinkOut - more resources